At the beginning of 2020, coronavirus disease 2019 (COVID-19) emerged as a new
pandemic, leading to a worldwide health crisis and overwhelming healthcare systems due to …

New‐onset atrial fibrillation (NOAF) in COVID‐19 raises significant clinical and public health
issues. This systematic review and meta‐analysis aims to compile and analyze the current …

The molecular mechanisms of sarcomere proteins underlie the contractile function of the
heart. Although our understanding of the sarcomere has grown tremendously, the focus has …

Background Atrial fibrillation (AF) is associated with substantial morbidity and mortality. New-
onset AF (NOAF) has been related recently to SARS-CoV-2 infection; however, the evidence …

New-onset atrial fibrillation (NOAF) is the most frequently encountered cardiac arrhythmia
observed in patients with COVID-19 infection, particularly in Intensive Care Unit (ICU) …

Introduction Atrial fibrillation (AF) and heart failure (HF) commonly coexist, resulting in
adverse health and economic consequences such as declining ventricular function …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) leads to coronavirus
disease-2019 (COVID-19) which can cause severe cardiovascular complications including …

Background Population‐based data on heart failure (HF)‐related death in patients with atrial
fibrillation (AF) are lacking. We assessed HF‐related death in people with AF in the United …

Introduction The recommended cardiac rhythm evaluation to determine the etiology of
ischemic stroke (IS) is similar in all patients regardless of their age and includes an …

Objective To assess the impact of new-onset atrial fibrillation (AF) on patients hospitalized
with coronavirus disease 2019 (COVID-19). Methods Multicenter and retrospective study …